Dolby Laboratories Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 17 trades in Dolby Laboratories (NYSE: DLB) since 2015, across 6 members, worth an estimated $185.01K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 10 buys against 7 sells, a modestly buy-led skew, with Democratic members responsible for 13% of the trades and Republican members 87%. The most recent disclosure shown was filed October 2025, and Lisa McClain has filed the most DLB transactions among those shown, with 4. One notable disclosed move was a purchase by Lisa McClain on September 11, 2025, down 6.7% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Dolby Laboratories's current Quantellect Tide Score is 52 out of 100 (High Tide), Top 45% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Dolby Laboratories (DLB) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Dolby Laboratories congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Lisa McClain House | Oct 23, 2025 | Sep 25, 2025 | 28 days | SELL |  $1,001 - $15,000 | -5.80% | Spouse | |
Lisa McClain House | Oct 22, 2025 | Sep 25, 2025 | 27 days | SELL | $1,001 - $15,000 | -5.80% | Spouse | |
Lisa McClain House | Oct 23, 2025 | Sep 11, 2025 | 42 days | BUY | $1,001 - $15,000 | -6.73% | Spouse | |
Lisa McClain House | Oct 22, 2025 | Sep 11, 2025 | 41 days | BUY | $1,001 - $15,000 | -6.73% | Spouse |
Dolby Laboratories (DLB) congressional trading FAQ
Can members of Congress legally trade Dolby Laboratories (DLB) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Dolby Laboratories (DLB), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Dolby Laboratories (DLB) trades public?
Yes. Every congressional trade in Dolby Laboratories (DLB) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Dolby Laboratories (DLB)?
Members of Congress have disclosed 17 trades in Dolby Laboratories (DLB) worth $185.01K across 6 members, according to public STOCK Act filings.
Which members of Congress have traded Dolby Laboratories (DLB)?
Recent and active filers of Dolby Laboratories (DLB) disclosures include Lisa McClain. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Dolby Laboratories (DLB) more?
Across disclosed Dolby Laboratories (DLB) trades, 12% were by Democrats and 82% by Republicans, led by Republicans (82%).
What is the most recent congressional Dolby Laboratories (DLB) trade?
The most recent disclosed Dolby Laboratories (DLB) trade was a purchase by Lisa McClain, filed Oct 22, 2025.
What is Dolby Laboratories (DLB)'s Tide Score?
Dolby Laboratories (DLB) has a Quantellect Tide Score of 52 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewDolby Laboratories (DLB) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.